Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity (abst – 2001)http://www.ncbi.nlm.nih.gov/pubmed/11828716
Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12921861
The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney (abst - 2008)http://www.ncbi.nlm.nih.gov/pubmed/18571910
Effects of Cannabinoids on Caffeine Contractures in Slow and Fast Skeletal Muscle Fibers of the Frog (full - 2009)http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20685770
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats (full – 2012)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578305/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and "Triptan" Receptors: Implications in Migraine (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells (full – 2013)http://www.nature.com/cddis/journal/...is2013151a.pdf
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23463621
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF- 2014)http://www.impactjournals.com/oncota...e&op=view&path[]=2233
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24218022
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24561046
Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12921861
The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney (abst - 2008)http://www.ncbi.nlm.nih.gov/pubmed/18571910
Effects of Cannabinoids on Caffeine Contractures in Slow and Fast Skeletal Muscle Fibers of the Frog (full - 2009)http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20685770
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats (full – 2012)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578305/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and "Triptan" Receptors: Implications in Migraine (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells (full – 2013)http://www.nature.com/cddis/journal/...is2013151a.pdf
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23463621
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF- 2014)http://www.impactjournals.com/oncota...e&op=view&path[]=2233
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24218022
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24561046